Cancer Drug Resistance Template
Get your Cancer Drug Resistance paper right the first time: a ready-made structure with the right abstract and citations, so editors see your science, not formatting slips.
4.6
How to Use the Cancer Drug Resistance Template | A Step-by-Step Guide
Authored by Sumalatha Gangadhar | Published on 3 August, 2026
Submitting to Cancer Drug Resistance goes smoothly when your draft already matches the journal's own rules. Editors screen new manuscripts against the Cancer Drug Resistance guide for authors before peer review, so formatting, structure, and required statements should be right on the first draft rather than repaired during upload. This template sets that structure up for you.
What is the Cancer Drug Resistance Template?
It is a manuscript shell aligned to Cancer Drug Resistance. It covers front matter, the abstract the journal expects, a body organized to the journal's article types, and a reference list in the journal's required style. Confirm current scope and article types on the Cancer Drug Resistance journal page before you draft.
What's actually in a Cancer Drug Resist submission:
Prepare the title, authors, affiliations, and ORCID iDs. Write the abstract to the journal's rule and word limit, organize the body to the article type, and apply the required reference style from the first citation. Complete every declaration (ethics, competing interests, funding, data availability) the Cancer Drug Resistance guide for authors lists, and cite figures and tables in order.
What separates a clean submission from one that gets kicked back:
The common failure modes are formatting or reference style that does not match the guide for authors, missing required statements, and an incomplete portal checklist. Clear all three against the Cancer Drug Resistance guide for authors before you submit.
What does this Cancer Drug Resistance Template include?
The shell mirrors what editorial staff check first: article-type fit, the abstract rules, required declarations, and the journal's reference style. For more detail see the author resources. When your draft is ready, upload it through the journal's submission system.
Steps to Use This Template with SciSpace Agent
- Click Start Writing on this page. The SciSpace Agent prompt screen opens with the template loaded.
- Use the loaded template, or upload a version your group already uses for Cancer Drug Resist.
- Edit the prompt with your topic and article type, and note any requirement from the Cancer Drug Resistance guide for authors.
- Run the prompt. The agent drafts into the correct structure and reference style.
- Use View Outputs to verify required statements and formatting are present.
- Export and submit through the journal's submission system.
Cancer Drug Resistance Template Structure at a Glance
| Element | Cancer Drug Resist requirement |
|---|---|
| Abstract | Original Articles, Systematic Reviews, and Meta-Analyses: Structured abstract with sections Aim, Methods, Results, Conclusion; ≤250 words. Reviews: Unstructured abstract; ≤250 words. Technical Note and Commentary: Unstructured abstract; ≤250 words. Perspective: Unstructured abstract; ≤150 words. Editorial: No abstract required. Letter to Editor and Opinion: Optional abstract; ≤250 words if included. The abstract must not contain citations, must emphasize new and important aspects, note limitations, and not overinterpret findings. Clinical trial abstracts must include CONSORT-identified essential items |
| Main text | Original Article, Review, Meta-Analysis, Systematic Review: No overall word limit specified. Technical Note: ≤1500 words main text. Commentary: Max 1,500 words. Editorial: Max 1,000 words. Letter to Editor: Max 1,000 words. Opinion: Max 1,500 words. Perspective: Max 3,000 words (excluding references, figures, tables). Section order for Original Articles: Introduction, Methods, Results, Discussion, Conclusion. Reviews have flexible structure but recommended: Introduction, multiple sections, Conclusion |
| Declarations | Ethics approval/consent as applicable; competing interests; funding; data availability |
| Figures/tables | Publication-ready; cited in order |
| Supplemental | Upload separately when used |
| Keywords | 3-8 keywords required for most article types (Original Article, Review, Meta-Analysis, Systematic Review, Technical Note, Commentary, Opinion, Perspective). Keywords should be specific to the article yet reasonably common within the subject discipline. Editorial: no keywords required. Letter to Editor: keywords optional |
| References | Numbered citation style (Vancouver-style). References numbered in order of appearance in square brackets. Journal abbreviations based on Index Medicus. For ≤6 authors, list all names; for >6 authors, list first three authors followed by 'et al.'. Include PMID and DOI when available. Format: Author(s). Title. Journal abbreviation. Year;Volume:Pages. [PMID: xxx DOI: xxx] |
| Peer review | Single-blind peer review. The journal operates a rigorous single-blind peer review process with at least two independent reviewers, followed by a final decision by the Editor-in-Chief. Reviewers' identities are not released to authors or other reviewers unless reviewers voluntarily sign their comments. The journal also states it supports double-blind peer-review and open review in the future |
| Submission | www.oaecenter.com/login?JournalId=cdr |
Quick Tips for Using the Cancer Drug Resistance Template
Read the Cancer Drug Resistance guide for authors once before drafting and once before upload. Draft the abstract after results are stable. Set the reference style before adding citations. Keep a cover letter that states your contribution and fit to Cancer Drug Resistance in under a page.
Best Practices
Skim two or three recent Cancer Drug Resist papers to calibrate depth and figure style. Make the novelty clear in the first two pages. Deposit data and code when the policy on the Cancer Drug Resistance journal page requires it. Disclose any preprint or conference version with identifiers in the cover letter.
Before You Submit: Final Check
Do one focused pass against the Cancer Drug Resistance guide for authors: scope, length, reference style, required declarations, and figure quality. Then submit through the journal's submission system.
